Legend Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
2,518
+571
+29% +$583K 1.64% 13
2026
Q1
$1.79M Buy
1,947
+17
+0.9% +$17.2K 1.12% 16
2025
Q4
$2.07M Buy
+1,930
New +$1.85M 1.16% 13

Other funds holding LLY

Legend Capital Advisors's LLY Position: Q2 2026 in Review

Legend Capital Advisors increased its Eli Lilly (LLY) stake by 29% in Q2 2026, buying an estimated $583K and bringing the position to 2,518 shares worth $3.02M. The position accounts for 1.64% of the portfolio, ranked #13.

Legend Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legend Capital Advisors held 2,518 shares of Eli Lilly worth $3.02M as of Q2 2026.
  • Legend Capital Advisors bought 571 Eli Lilly shares in Q2 2026, an estimated $583K.
  • Eli Lilly made up 1.64% of Legend Capital Advisors's portfolio in Q2 2026, its #13 holding.
  • Legend Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legend Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.